Clinical Trial

CTFFR and Prediction of Non-Significant CAD Lesions

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 21, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this prospective cohort study, 250 patients with suspected or known CAD and at least one intermediate coronary lesion (50-70% stenosis) who had a NiFFR value greater than 0.80 underwent coronary computed tomography angiography (CCTA) with NiFFR assessment. Patients were followed for one year to monitor for MACE
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-16.
Trial Details
NCT Number NCT06979427
Lead Sponsor Shiraz University of Medical Sciences
Conditions Chronic Coronary Syndrome
Enrollment 250 participants
Start Date 2024-01-01
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-21